Drug Trial Radar · NCT06580041
Precision Care for Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
150
Planned (sponsor's estimate)
Start
Nov 12, 2024
Primary completion
Sep 1, 2029
Study completion Sep 1, 2029
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to assess whether phenotyping-guided intervention selection is superior to intervention selection without phenotyping guidance (i.e., routine clinician and patient judgment regarding treatment selection) for depression.
Conditions
- Major Depressive Disorder
- Depression
- Depressive Disorder, Major
Interventions
PramipexoleDrug
CAU plan modified to include a trial of pramipexole.
MethylphenidateDrug
CAU plan modified to include a trial of methylphenidate (or, if contraindicated: guanfacine).
PhenelzineDrug
CAU plan modified to include a trial of phenelzine (or, if contraindicated: brexpiprazole).
Mindfulness-based Stress Sensitivity Therapy (MBSST)Behavioral
CAU plan modified to include a trial of MBSST. MBSST is an individual psychotherapy delivered approximately weekly for 16 sessions.
Complicated Grief Treatment (CGT)Behavioral
CAU plan modified to include a trial of CGT.
Care as usual (CAU) planOther
Unmodified CAU plan.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quick Inventory of Depressive Symptoms - Self-Report 16-Item (QIDS-SR-16) scoreTime frame: Up to 24 weeks after randomization.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nancy Friend Pritzker Psychiatry Building, University of California, San Francisco
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.